Quarterly report · Q3
4005.TEDINET S100Q3KZ
Period2022-04-01 → 2022-12-31
Filed2023-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 59
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.26T | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥728.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥2.77T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.04T | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥712.7bn | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥71.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.9bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥197.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥53.7bn | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥94.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥32.0bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥251.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥209.5bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥62.8bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥60.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥20.8bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥162.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥133.7bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥44.8bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥41.7bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥31.4bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥186.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥155.7bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥47.9bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥4.55T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥4.31T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥4.23T | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.75T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.61T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.80T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.70T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.61T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.48T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.31T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.22T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.13T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥499.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥365.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥390.4bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥360.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥100.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥171.7bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥99.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | ¥1.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥115.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥85.1bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥13.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥81.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥4.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥36.89 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-12.69 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥99.16 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥81.75 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥27.39 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥36.88 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-12.69 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 28.8% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.3% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.7% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 123
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥128.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-10-01 → 2022-12-31 | ¥48.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥64.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-10-01 → 2022-12-31 | ¥26.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥63.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥21.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥7.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-10-01 → 2022-12-31 | ¥5.1bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥85.5bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥28.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥85.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥28.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥14.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥2.8bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥270.7bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥87.0bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥257.1bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥83.6bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥13.6bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥16.9bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥680.1bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥209.8bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥675.5bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥208.2bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥2.0bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2022-10-01 → 2022-12-31 | −¥25.3bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥442.3bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥146.4bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥439.2bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥145.3bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥10.9bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥338.9bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥116.5bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥338.6bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥116.4bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥350m |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥116m |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥43.7bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥17.3bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥482.5bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥148.1bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥482.5bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥148.0bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥14m |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥7m |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥43.1bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥17.9bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥2.21T |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥707.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥2.19T |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥701.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21.7bn |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥6.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥148.9bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥24.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥93.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-10-01 → 2021-12-31 | ¥33.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥46.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-10-01 → 2021-12-31 | ¥16.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥46.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥17.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥12.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-10-01 → 2021-12-31 | ¥5.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥63.7bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2021-12-31 | −¥22.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥63.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2021-12-31 | −¥22.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥13.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2021-12-31 | −¥2.9bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥236.1bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥81.6bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥226.7bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥78.2bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥3.4bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥18.6bn |
| jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥6.1bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥629.1bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥226.9bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥625.0bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥225.5bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥4.1bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥52.0bn |
| jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥10.0bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥334.8bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥122.1bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥331.0bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥121.5bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥3.9bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥523m |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥27.8bn |
| jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥352.4bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥124.5bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥352.1bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥124.4bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥335m |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥109m |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥46.0bn |
| jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥16.4bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥456.3bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥146.7bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥456.3bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥146.7bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9m |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥62.5bn |
| jpcrp040300-q3r_E00752-000Medical Productsreportable segment | segment profit | 2021-10-01 → 2021-12-31 | ¥12.5bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥2.01T |
| —segment total | revenue | 2021-10-01 → 2021-12-31 | ¥701.8bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥1.99T |
| —segment total | revenue external | 2021-10-01 → 2021-12-31 | ¥696.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥17.7bn |
| —segment total | revenue intersegment | 2021-10-01 → 2021-12-31 | ¥5.5bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥206.9bn |
| —segment total | segment profit | 2021-10-01 → 2021-12-31 | ¥54.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,020
| Item | Context | Value | Unit |
|---|---|---|---|
| Dividends paid fin cf IFRS | Prior1YTDDuration | -31083000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -42502000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -10339000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -13034000000 | JPY |
| Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRS | Prior1YTDDuration | -3958000000 | JPY |
| Payments for acquisition of interests in subsidiaries from non controlling interests fin cf IFRS | CurrentYTDDuration | － | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 3152000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 911000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | 4466000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | 12983000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 11111000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 21633000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 29521000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 136623000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 360918000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 365429000000 | JPY |
| Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRS | Prior1YTDDuration | － | JPY |
| Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRS | CurrentYTDDuration | -2458000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 390439000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 499594000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember | 624950000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember | 226672000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000InformationElectronicChemistryReportableSegmentMember | 352085000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember | 330961000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000MedicalProductsReportableSegmentMember | 456266000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1990934000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 46943000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration | 2037877000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember | 4123000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember | 9381000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000InformationElectronicChemistryReportableSegmentMember | 335000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember | 3852000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000MedicalProductsReportableSegmentMember | 9000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 17700000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 46030000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -63730000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration | － | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember | 629073000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember | 236053000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000InformationElectronicChemistryReportableSegmentMember | 352420000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember | 334813000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000MedicalProductsReportableSegmentMember | 456275000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 2008634000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 92973000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -63730000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 2037877000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember | 51997000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember | 18629000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00752-000InformationElectronicChemistryReportableSegmentMember | 45968000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |